Role of N6-Methyladenosine Methylation Regulators in the Drug Therapy of Digestive System Tumours

Role of N6-Methyladenosine Methylation Regulators in the Drug Therapy of Digestive System Tumours

Digestive system tumours, including stomach, colon, esophagus, liver and pancreatic tumours, are serious diseases affecting human health. Although surgical treatment and postoperative chemoradiotherapy effectively improve patient survival, current diagnostic and therapeutic strategies for digestive...

Full description

Bibliographic Details
Main Authors:	Zhelin Xia, Fanhua Kong, Kunpeng Wang, Xin Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Pharmacology
Subjects:	digestive system tumors N6-methyladenosine drug resistance chemotherapy immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.908079/full

Similar Items

The roles of RNA N6-methyladenosine in esophageal cancer
by: Chuan Teng, et al.
Published: (2022-11-01)

The importance of N6-methyladenosine modification in tumor immunity and immunotherapy
by: Ze Zhang, et al.
Published: (2022-05-01)

N6-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target
by: Chao Quan, et al.
Published: (2021-08-01)

Links Between N6-Methyladenosine and Tumor Microenvironments in Colorectal Cancer
by: Yundi Zhang, et al.
Published: (2022-02-01)

N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy
by: Meng-Meng Zhang, et al.
Published: (2021-12-01)

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
by: Liting Guo, et al.
Published: (2021-12-01)

Roles and implications of mRNA N6‐methyladenosine in cancer
by: Lingxing Zeng, et al.
Published: (2023-07-01)

Targeting RNA N 6-methyladenosine modification: a precise weapon in overcoming tumor immune escape
by: Wei Li, et al.
Published: (2022-09-01)

N6-methyladenosine RNA methylation: From regulatory mechanisms to potential clinical applications
by: Peipei Li, et al.
Published: (2022-11-01)

Epigenetic regulation of N6‐methyladenosine modifications in obesity
by: Mingli Sun, et al.
Published: (2021-08-01)

Role of N6-methyladenosine methylation in glioma: recent insights and future directions
by: Chunlin Li, et al.
Published: (2023-12-01)

Potential roles of N6-methyladenosine (m6A) in immune cells
by: Chang Liu, et al.
Published: (2021-06-01)

RNA N6-methyladenosine methylation and skin diseases
by: Yaqin Yu, et al.
Published: (2023-12-01)

Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy
by: Xianyong Zhou, et al.
Published: (2023-02-01)

N6-Methyladenosine RNA Methylation in Cardiovascular Diseases
by: Chi Liu, et al.
Published: (2022-04-01)

The Potential Roles of RNA N6-Methyladenosine in Urological Tumors
by: Yang Li, et al.
Published: (2020-09-01)

The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance
by: Zhaolin Chen, et al.
Published: (2022-04-01)

N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
by: Zhang Meijing, et al.
Published: (2022-06-01)

Transcriptome-wide N6-methyladenosine methylation profile of atherosclerosis in mice
by: Xinbin Zheng, et al.
Published: (2023-12-01)

The emerging roles of N6-methyladenosine RNA methylation in human cancers
by: Huafei Shen, et al.
Published: (2020-06-01)

Role of N6-Methyladenosine (m6A) Methylation Regulators in Hepatocellular Carcinoma
by: Nanfang Qu, et al.
Published: (2021-10-01)

Effects of N6-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy
by: Yong-fu Zhu, et al.
Published: (2022-05-01)

Roles of N6-methyladenosine (m6A) modifications in gynecologic cancers: mechanisms and therapeutic targeting
by: Jiahua Chen, et al.
Published: (2022-11-01)

Role of m6A modification in immune microenvironment of digestive system tumors
by: Chao Li, et al.
Published: (2023-08-01)

Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer
by: Qiang Liu
Published: (2022-01-01)

Functions of N6-methyladenosine and its role in cancer
by: Liuer He, et al.
Published: (2019-12-01)

Crosstalk between N6-methyladenosine modification and circular RNAs: current understanding and future directions
by: Xin Wang, et al.
Published: (2021-09-01)

N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer
by: Mingyang Ma, et al.
Published: (2022-11-01)

Functions of N6-methyladenosine in cancer metabolism: from mechanism to targeted therapy
by: Jiayi He, et al.
Published: (2023-04-01)

The emerging roles of N6-methyladenosine in osteoarthritis
by: Hui Liu, et al.
Published: (2022-11-01)

N6-methyladenosine modification contributes to respiratory syncytial virus infection
by: Zhu Li, et al.
Published: (2023-04-01)

The Epigenetic Regulation of RNA N6-Methyladenosine Methylation in Glycolipid Metabolism
by: Haiqing Yang, et al.
Published: (2023-02-01)

Multilevel regulation of N6-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities
by: Lili Feng, et al.
Published: (2023-09-01)

Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma
by: Yong Liu, et al.
Published: (2022-01-01)

Integrated Analyses of m<sup>6</sup>A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Pan-Cancer
by: Qingkang Cao, et al.
Published: (2022-09-01)

The functions of N6-methyladenosine modification in lncRNAs
by: Rong-Zhang He, et al.
Published: (2020-12-01)

N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1
by: Jing Li, et al.
Published: (2024-04-01)

Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology
by: Gong Zhang, et al.
Published: (2023-03-01)

N6-methyladenosine (m6A) RNA modification in tumor immunity
by: Siyi Zheng, et al.
Published: (2022-04-01)

N6-methyladenosine modification in ischemic stroke: Functions, regulation, and therapeutic potential
by: Fei Han
Published: (2024-02-01)